Gold: Narrowing Range, Cautiously Bullish

Spot gold has been trading within a narrowing range in the last few weeks, ahead of the upcoming Fed FOMC meeting...

Gold 4

Spot gold has been trading within a narrowing range in the last few weeks, after volatile trading in early August. Pharmaceutical giant AstraZeneca and the University of Oxford said clinical trials for their coronavirus vaccine AZD1222 have resumed in the UK, following confirmation by the Medicines Health Regulatory Authority that it was safe to do so.


While gold prices have been dragged by vaccine development, investors continue to expect the Federal Reserve, which will hold a two-day monetary policy meeting mid-week, to keep its dovish stance.


From a technical point of view, spot gold maintains a bullish bias as shown on a daily chart. It is trading within a symmetrical triangle pattern, while support is provided by the ascending 50-day moving average. The level at $1,900 might be considered as the nearest support, with the 1st and 2nd resistance likely to be located at $2,015 and $2,075 respectively. Alternatively, a break below $1,900 would suggest that a deeper price correction is due and open a path to the next support at $1,865.




Source: Gain Capital, TradingView

More from Gold

Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.